Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

Multiple Sclerosis

Spinal cord volume loss: A marker of disease progression in multiple sclerosis

Neurology.

Tsagkas C, Magon S, Gaetano L, Pezold S, Naegelin Y, Amann M, Stippich C, Cattin P, Wuerfel J, Bieri O, Sprenger T, Kappos L, Parmar K

doi: 10.1212/

Multiple Sclerosis

Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis

Brain

Mariano R, Messina S, Roca-Fernandez A, Leite MI, Kong Y, Palace JA

doi: 10.1093/brain/awaa347

RECOMMENDED

Multiple Sclerosis

Central Slab versus Whole Brain to Measure Brain Atrophy in Multiple Sclerosis

Eur Neurol.

Ruberte E, Sinnecker T, Amann M, Gaetano L, Naegelin Y, Penner IK, Kuhle J, Derfuss T, Kappos L, Granziera C, Wuerfel J, Yaldizli Ö

doi: 10.1159/000495798.

RECOMMENDED

Multiple Sclerosis

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

Lancet Neurol.

Ciccarelli O, Cohen JA, Reingold SC, Weinshenker BG; International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders

doi: 10.1016/S1474-

RECOMMENDED

Aging and Cognitive FunctionsMultiple Sclerosis

Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis

Brain.

Brownlee WJ, Altmann DR, Prados F, Miszkiel KA, Eshaghi A, Gandini Wheeler-Kingshott CAM, Barkhof F, Ciccarelli O

doi: 10.1093/brain/awz156.

Multiple Sclerosis

Preferential spinal cord volume loss in primary progressive multiple sclerosis

Mult Scler.

Tsagkas C, Magon S, Gaetano L, Pezold S, Naegelin Y, Amann M, Stippich C, Cattin P, Wuerfel J, Bieri O, Sprenger T, Kappos L, Parmar K

doi: 10.1177/1352458518775006.

Multiple Sclerosis

Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis

Mult Scler.

Siller N, Kuhle J, Muthuraman M, Barro C, Uphaus T, Groppa S, Kappos L, Zipp F, Bittner S

doi: 10.1177/1352458518765666.

Multiple Sclerosis

Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.

JAMA Neurol.

Regev K, Healy BC, Khalid F, Paul A, Chu R, Tauhid S, Tummala S, Diaz-Cruz C, Raheja R, Mazzola MA, von Glehn F, Kivisakk P, Dupuy SL, Kim G, Chitnis T, Weiner HL, Gandhi R, Bakshi R

doi: 10.1001/

Multiple Sclerosis

Serum neurofilament light: A biomarker of neuronal damage in multiple sclerosis

Ann Neurol.

Disanto G, Barro C, Benkert P, Naegelin Y, Schädelin S, Giardiello A, Zecca C, Blennow K, Zetterberg H, Leppert D, Kappos L, Gobbi C, Kuhle J; Swiss MS Cohort Study (SMSC) Group

doi: 10.1002/ana.24954.

Related content

Spinal cord volume loss: A marker of disease progression in multiple sclerosis

Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis

Central Slab versus Whole Brain to Measure Brain Atrophy in Multiple Sclerosis

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis

Preferential spinal cord volume loss in primary progressive multiple sclerosis

Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis

Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.

Serum neurofilament light: A biomarker of neuronal damage in multiple sclerosis